Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells

References

• MalatsNRealFXEpidemiology of bladder cancerHematol Oncol Clin North Am201529177189vii25836927
   PubMed Web of Science ®Google Scholar
• van der MeijdenAPOptimal treatment for intermediate- and high-risk, nonmuscle-invasive bladder cancerScientific World Journal200662611261617619738
   PubMedGoogle Scholar
• DovediSJDaviesBREmerging targeted therapies for bladder cancer: a disease waiting for a drugCancer Metastasis Rev20092835536719997963
   PubMed Web of Science ®Google Scholar
• HashimotoIKoizumiKTatematsuMBlocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cellsEur J Cancer2008441022102918375114
   PubMed Web of Science ®Google Scholar
• LamouilleSDerynckRCell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayJ Cell Biol200717843745117646396
   PubMed Web of Science ®Google Scholar
• FariedLSFariedAKanumaTPredictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapyOncol Rep200616576316786123
   PubMed Web of Science ®Google Scholar
• HanselDEPlattEOrloffMMammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinomaAm J Pathol20101763062307220395440
   PubMed Web of Science ®Google Scholar
• FasoloASessaCmTOR inhibitors in the treatment of cancerExpert Opin Investig Drugs20081717171734
   PubMed Web of Science ®Google Scholar
• HuangJJLiZMHuangYSchedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugsInvest New Drugs20123022323520960030
   PubMed Web of Science ®Google Scholar
• HurvitzSAKalousOConklinDIn vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of responseBreast Cancer Res Treat201514966968025663547
   PubMed Web of Science ®Google Scholar
• LeeSJLeeJLeeJPhase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patientsInvest New Drugs2013311580158624013904
   PubMed Web of Science ®Google Scholar
• WedelSHudakLSeibelJMInhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001Life Sci20118841842421192952
   PubMed Web of Science ®Google Scholar
• MotzerRJEscudierBOudardSEfficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialLancet200837244945618653228
   PubMed Web of Science ®Google Scholar
• ErdemogluEGuneyMTakeGGiraySGMunganTRAD001 (Everolimus) can prevent tamoxifen-related endometrial and stromal hyperplasiaInt J Gynecol Cancer20091937537919407562
   PubMed Web of Science ®Google Scholar
• LiuEMarincolaPObergKEverolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretationsTherap Adv Gastroenterol20136412419
   PubMed Web of Science ®Google Scholar
• VignotSFaivreSAguirreDRaymondEmTOR-targeted therapy of cancer with rapamycin derivativesAnn Oncol20051652553715728109
   PubMed Web of Science ®Google Scholar
• LinJFTsaiTFLiaoPCBenzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signalingCarcinogenesis20133440641423172666
   PubMed Web of Science ®Google Scholar
• ChangCJLinJFChangHHLeeGAHungCFLutein protects against methotrexate-induced and reactive oxygen species-mediated apoptotic cell injury of IEC-6 cellsPLoS One20138e7255324039779
   PubMed Web of Science ®Google Scholar
• LinJFLinYCLinYHZoledronic acid induces autophagic cell death in human prostate cancer cellsJ Urol20111851490149621334668
   PubMedGoogle Scholar
• O’ReillyKERojoFSheQBmTOR inhibition induces upstream receptor tyrosine kinase signaling and activates AktCancer Res2006661500150816452206
   PubMed Web of Science ®Google Scholar
• PankivSClausenTHLamarkTp62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagyJ Biol Chem2007282241312414517580304
   PubMed Web of Science ®Google Scholar
• HuangSHoughtonPJTargeting mTOR signaling for cancer therapyCurr Opin Pharmacol2003337137712901945
   PubMed Web of Science ®Google Scholar
• WengrodJCGardnerLBCellular adaptation to nutrient deprivation: crosstalk between the mTORC1 and eIF2alpha signaling pathways and implications for autophagyCell Cycle2015142571257726039820
   PubMed Web of Science ®Google Scholar
• TangLZirpoliGRGuruKIntake of cruciferous vegetables modifies bladder cancer survivalCancer Epidemiol Biomarkers Prev2010191806181120551305
   PubMed Web of Science ®Google Scholar
• CamMBidHKXiaoLp53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damageJ Biol Chem20142894083409424366874
   PubMed Web of Science ®Google Scholar
• WallMPoortingaGStanleyKLThe mTORC1 inhibitor everolimus prevents and treats Emu-Myc lymphoma by restoring oncogene-induced senescenceCancer Discov20133829523242809
   PubMed Web of Science ®Google Scholar
• ZhangWBWangZShuFActivation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibitionJ Biol Chem2010285404614047120880848
   PubMed Web of Science ®Google Scholar
• AkenoNMillerALMaXWikenheiser-BrokampKAp53 suppresses carcinoma progression by inhibiting mTOR pathway activationOncogene20153458959924469052
   PubMed Web of Science ®Google Scholar
• SarbassovDDGuertinDAAliSMSabatiniDMPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complexScience20053071098110115718470
   PubMed Web of Science ®Google Scholar
• HsuPPKangSARamesederJThe mTOR-regulated phospho-proteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signalingScience20113321317132221659604
   PubMed Web of Science ®Google Scholar
• SabatiniDMmTOR and cancer: insights into a complex relationshipNat Rev Cancer2006672973416915295
   PubMed Web of Science ®Google Scholar
• SarbassovDDAliSMSenguptaSProlonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKBMol Cell20062215916816603397
   PubMed Web of Science ®Google Scholar
• CarracedoAMaLTeruya-FeldsteinJInhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerJ Clin Invest20081183065307418725988
   PubMed Web of Science ®Google Scholar
• CodognoPMeijerAJAutophagy and signaling: their role in cell survival and cell deathCell Death Differ200512Suppl 21509151816247498
   PubMed Web of Science ®Google Scholar
• HosokawaNHaraTKaizukaTNutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagyMol Biol Cell2009201981199119211835
   PubMed Web of Science ®Google Scholar
• SarkarSRavikumarBFlotoRARubinszteinDCRapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathiesCell Death Differ200916465618636076
   PubMed Web of Science ®Google Scholar
• GuertinDASabatiniDMAn expanding role for mTOR in cancerTrends Mol Med20051135336116002336
   PubMed Web of Science ®Google Scholar
• LamoureuxFZoubeidiADual inhibition of autophagy and the AKT pathway in prostate cancerAutophagy201391119112023670050
   PubMed Web of Science ®Google Scholar
• CaoCSubhawongTAlbertJMInhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cellsCancer Res200666100401004717047067
   PubMed Web of Science ®Google Scholar
• HuoYCaiHTeplovaIAutophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancerCancer Discov2013389490723650262
   PubMed Web of Science ®Google Scholar
• LeeHYChungKJHwangIHActivation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cellsMar Drugs20151354355725603347
   PubMed Web of Science ®Google Scholar
• ToshimaTShirabeKMatsumotoYAutophagy enhances hepatocellular carcinoma progression by activation of mitochondrial beta-oxidationJ Gastroenterol20144990791623702609
   PubMed Web of Science ®Google Scholar
• ShiYHanJJTennakoonJBAndrogens promote prostate cancer cell growth through induction of autophagyMol Endocrinol20132728029523250485
   PubMed Web of Science ®Google Scholar
• MorselliEGalluzziLKeppOAnti- and pro-tumor functions of autophagyBiochim Biophys Acta200917931524153219371598
   PubMed Web of Science ®Google Scholar
• LinYCLinJFWenSIInhibition of high basal level of autophagy induces apoptosis in human bladder cancer cellsJ Urol Epub20151028
   Web of Science ®Google Scholar
• PalIParidaSPrashanth KumarBNBlockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinomaEur J Pharmacol Epub20151015
   PubMed Web of Science ®Google Scholar
• LiLQXieWJPanDChenHZhangLInhibition of autophagy by bafilomycin A1 promotes chemosensitivity of gastric cancer cellsTumour Biol Epub2015815
   Google Scholar
• RuanYHuKChenHAutophagy inhibition enhances isorhamnetin-induced mitochondriadependent apoptosis in nonsmall cell lung cancer cellsMol Med Rep20151245796580626238746
   PubMed Web of Science ®Google Scholar
• XieXWhiteEPMehnertJMCoordinate autophagy and mTOR pathway inhibition enhances cell death in melanomaPLoS One20138e5509623383069
   PubMed Web of Science ®Google Scholar
• RangwalaRChangYCHuJCombined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanomaAutophagy2014101391140224991838
   PubMed Web of Science ®Google Scholar